- Fapon Biotech COVID-19 Testing Raw Materials Experimentally Proved to Be Effective on Omicron Variant Detection
(Chicago, USA, August 28, 2022) Fapon Biotech is pleased to announce its attendance as an IVD empowering partner exhibitor on 2022 AACC Annual Scientific Meeting & Clinical Lab Expo (2022 AACC), which is held at McCormick Place Convention Center in Chicago, IL, USA during August 26th-28th. While the AACC expo is well known for showcasing the cutting-edge science and technology shaping the future of laboratory medicine, Fapon Biotech will bring about its excellent IVD core raw materials, reagent solutions and open instruments at booth 3244.
（Fapon Biotech AACC Booth#3244）
It is worth mentioned that the Company team is honored to have the AACC leadership’s visit at Fapon Bioteh’s booth 3244 on the opening day of the expo, July 26th. The AACC leadership has awarded Fapon Biotech as 2022 AACC Bronze Supporter for its continued partnership and support. In addition, the entire Fapon Biotech team has received a ribbon that recognized the Company’s level of support. Congratulations on Fapon Biotech’s partnership with AACC leadership! This could be a big step for the Company to further penetrate the North America IVD market and provide more comprehensive and optimized IVD products to local IVD partners.
（ Fapon Biotech was awarded as 2022 AACC Bronze Supporter by the AACC leadership）
Since year 2007, Fapon Biotech has entered international market for over 15 years, innovatively showcasing its IVD products to worldwide partners and closely connecting with the industry with more solutions. According to the latest statistics, Fapon Biotech’s global market has covered over 61 countries or regions and its international business revenue accounted for 40%.
(Fapon Biotech booth reception desks were fully sitted by visitors, talking business)
As in other previous exhibitions, Fapon Biotech’s excellent raw materials still gained the greatest attentions and favors form visitors. Highlighted raw materials and reagent solutions for both immunoassay and molecular diagnostics platforms are well introduced by the Company’s on-site sales and technical supporters, such as cardiac marker, tumor marker, respiratory disease, inflammatory marker, tropical disease, infectious disease, drug of abuse, Polymerase & Mix, Reverse Transcriptase & Mix, LAMP Polymerase, PCR Miscellaneous, etc. As a leading supplier of excellent IVD raw materials and customized solutions, Fapon Biotech has continuously developed and optimized its product portfolio to accelerate downstream diagnostic companies’ disease testing.
(Fapon Biotech team enjoyed discussing its highlighted IVD raw materials with its customers)
Besides, attendees also showed great interests in the open instruments demonstrated at the booth, especially the chemiluminescence immunoassay analyzers, namely Shine i1000 and Shine i2000. The analyzers are designed with open system, which allows them compatible with AE/AP/HRP/ABEI chemiluminescence assay protocals. Based on the immunoassay analyzers, Fapon Chemiluminescence one-stop solution shows up. Fapon Biotech is dedicated to empowering partners to research and manufacture chemiluminescence reagents locally, with our open instrument platform, innovative core raw materials, reagent solutions, and other efficient support.
(Attendees showed great interests in Fapon Biotech's open instrument platforms)
(Fapon Biotech‘s international sales director, Joe Man, was enthusiastically introducing Fapon Biotech Chemiluminiscence one-stop solution to visitors)
Alongside with the immunoassay analyzers, another two of Fapon Biotech’s open instrument platforms are rapid molecular diagnostic system, namely P810 and iCatch 2000. P810 real-time PCR instrument is a real-time fluorescence quantitative PCR analyzer, designed for scientific research and medical applications which integrates nucleic acid amplification, result analysis and report delivery. iCatch 2000 is a fully automatic nucleic acid analyzer which can realize sample-to-answer automation within 30mins. The two open instruments and supporting excellent raw reagent materials have demonstrated Fapon Biotech’s strength in the field of molecular diagnosis.
(Fapon Biotech's rapid molecular diagnostic system gained great attentions from IVD partners)
Congratulation on Fapon Biotech’s another splendid showcase at 2022 AACC. Deep gratitude to all guests who visited and expressed their supports to us.